Navigation Links
InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
Date:9/13/2010

ttee (PADAC) voted 9 to 3 to recommend that the U.S. Food and Drug Administration (FDA) approve pirfenidone to reduce decline in lung function in patients with IPF, this result was not binding on the FDA and the FDA subsequently issued a Complete Response letter requesting an additional clinical trial to support the efficacy of pirfenidone in IPF. While we will work diligently with the FDA to determine a path forward with respect to pirfenidone in the United States, we do not currently know where that path will lead and there can be no assurance that the FDA will ultimately grant InterMune approval for the use of pirfenidone for the treatment of IPF irrespective of whether InterMune conducts an additional clinical study as requested by the FDA in the Complete Response letter.

Other factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the SEC on March 15, 2010 (the "Form 10-K"), and other periodic reports filed with the SEC, including the following: (i) risks related to the long, expensive and uncertain clinical development and regulatory process, including having no unexpected safety, toxicology, clinical or other issues or delays in anticipated timing of the regulatory approval process; (ii) risks related to failure to achieve the clinical trial results required to commercialize our product candidates; and (iii) risks related to timely patient enrollment and retention in clinical trials. The risks and other factors discussed above should be considered only in connection with the fully discussed risks and other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC. InterMune undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in InterMune's expecta
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune to Release Second Quarter Financial Results on July 27
2. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
3. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
4. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
5. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
6. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
7. InterMune to Present at Deutsche Bank Biotech Confab
8. InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
9. InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
10. InterMune to Present at JMP Securities Conference
11. InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... P&S Market Research releases ... DRO analysis, market segmentation, market size and forecast, ... competitor profiles in: Global Industry Insight: ... Demand Forecast to 2020       (Logo: ... reports with detailed TOC on Global Drug of ...
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. This report describes ... veterinary medicine and pharmaceuticals as well as improvement ... important in the application of biotechnology to manage ...
(Date:8/4/2015)... Among 1,000 U.S. consumers, the majority (65.3 ... consumers surveyed are aware of prescription savings cards, and ... according to findings from a new survey released today ... on improving the health and well-being of individuals, families ... men and women, ages 21 and older, on their ...
Breaking Medicine Technology:Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 2Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 3Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 4Global Drug of Abuse (DOA) Testing Market (Size of $2.9 Billion in 2014) to Witness 5% CAGR During 2015 - 2020 5Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3
... May 11 Despite significant international travel restrictions ... UBM International Media and sister company UBM Japan Co. Ltd. ... 2010 Japanese Pharma events cluster, which took place from 21-23 ... an increase of 3.8% over 2009 attendance levels, the success ...
... RF Technologies®, a leading provider of healthcare safety and security solutions, ... Safe Place® Infant Security Solutions. The soft, stretchy banding material and technologically ... a Safe Place bracelet is loose, tampered with or is cut. ... Smart Sense was developed ...
Cached Medicine Technology:UBM Japan Pharma Events Grow Despite Air Travel Disruptions 2UBM Japan Pharma Events Grow Despite Air Travel Disruptions 3UBM Japan Pharma Events Grow Despite Air Travel Disruptions 4Smart Sense(TM) From RF Technologies Upgrades Safe Place(R) Bracelets Using Industry-Leading Infant Security Technology, Fit and Comfort 2
(Date:8/4/2015)... ... August 05, 2015 , ... Renowned review site BestMillionaireDatingSites.com recently refreshed its list ... has been ranked as the best dating service in the segment. , A representative ... It is essential that people find the right dating platform so that they can ...
(Date:8/4/2015)... ... August 05, 2015 , ... The National Association ... inductee into its VIP Woman of the Year Circle. She is recognized with ... organization exclusively for professional women, boasting more than 700,000 members and over 200 ...
(Date:8/4/2015)... ... ... NOVA Pride , Northern Virginia’s largest and newest LGBTQ nonprofit organization, ... join them in paving “The Road Ahead” at the second annual Northern Virginia Pride ... 2015, from 12-9pm. In order to ensure the success of this important event, NOVA ...
(Date:8/4/2015)... ... 2015 , ... How cool is it to check in at your favorite ... "Now" feature will soon allow you to do just that. , Ahhaa is releasing ... the now feature. , Users will soon get to share what inspires them about ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Statement by Paul ... the introduction of the Mental Health Reform Act of 2015 by Senators ... mental health reform a reality in America. , “This legislation and H.R. ...
Breaking Medicine News(10 mins):Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3
... a device to monitor diabetics' blood sugar levels and ... on finger-prick blood tests and injections. ,The ... computer to monitor the patient's blood sugar levels and ... a media report. ,The key is the ...
... playing in the park; ,Age is grey,a toothless hag ... four lines reflect the glory of youth and the dismal ... romanticize youth, they shrink from the thought of greying hair, ... infirmities of old age. ,With the changing ...
... of anabolic steroids is linked to criminal activity such ... study published on Monday. // ,The ... of the muscle-building drugs however also revealed that steroid ... violent crimes such as murder, assault, rape and property ...
... Canadians are getting heavier , but a new study by Statistics Canada ... the same pace as they did earlier. //Adults between 18-64 were ... The data showed that they have put on weight steadily , but ... decreased. ,This welcome news is thought to be due to the ...
... have no one to look out for them. They are ... in the community without any money or family of their ... condition that impairs their judgment or ability to communicate. ... baby boomers age. ,There is only one state-funded program ...
... many parts of the world, the moral and legal aspects ... Various methods of inducing //abortions have been used throughout history ... crossed five in North America, who died from toxic shock ... people questioning the safety of the combination of the drugs ...
Cached Medicine News:Health News:Botox – The 'Celebrity' Dru 2Health News:Steroid Use Linked to Crimes 2Health News:Hoosiers Live at the Mercy of Nursing Homes 2Health News:Hoosiers Live at the Mercy of Nursing Homes 3Health News:Medically Induced Abortions (MIAs) Causes More Deaths Due To Infection 2
Maxi XL Hybridization Oven for Extra Large bottles. 6 bottle (70 mm) rotisserie + shaker tray available for simultaneous use. Includes linear and orbital shaker trays, 4 extra large bottles, pack o...
... Dimensions (WxDxH): 31.1 x 13.6 x 15.3 ... 22.4 x 20.5 cm, Capacity: 4 - ... x 35 mm bottles, 4 - 150 ... 240 x 80 mm bottle, Power Requirements: ...
... : Temperature controlled oven containing a rotisserie ... incubation of Northern, Southern and Western blots. ... and staining. Use of bottle hybridizations allows ... enhanced sensitivity and reduced reagent costs. Acrylic/polycarbonate ...
... Minifold I system consists of four basic components: ... and metal clamping plate (see diagram). The sample ... producing spots, dots, or slots (see below). All ... as an accessory plate in conjunction with a ...
Medicine Products: